Our results suggest that CAPN1 and GLRX3 may play important roles in the pathogenesis of lung adenocarcinoma, and that the variants may be useful in predicting the prognosis of lung adenocarcinoma after surgery, thereby helping to refine therapeutic decisions for better clinical outcomes in NSCLC. The gene discussed is CAPN1; the disease is non-small cell lung carcinoma.